Jinkais Shengke: The three shareholders plan to collectively reduce their holdings by no more than 4.3%.

Jin Kaisheng Biological announced that the company's shareholders Qilu Investment, Qingsong Investment, and Blue Area Fund plan to reduce their holdings of the company's shares due to their own capital needs. Qilu Investment intends to reduce its holdings by no more than 2,771,700 shares, accounting for 2.30% of the total share capital, through centralized bidding and block trading. Qingsong Investment and Blue Area Fund plan to reduce their holdings by no more than 1,204,000 shares each, accounting for 1% of the total share capital, through centralized bidding. The centralized bidding reduction will be carried out within three months after fifteen trading days from the announcement date, and the block trading will be conducted within three months after three trading days from the announcement date. This reduction will not lead to a change in the company's controlling rights.